Reporting owner
Farag Kameel D.
Reporting owner CIK 0002093620 · Interim CFO
These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.
Transaction timeline
Who reported an acquisition, and when the transaction occurred.
5 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.
View timeline as a table
| Transaction date | Company / security | Reporting owners | Acquisition type |
|---|---|---|---|
| Dec 16, 2025 | Akari Therapeutics PlcPre-Funded Warrants to purchase ADRs | Farag Kameel D. | Purchase |
| Dec 16, 2025 | Akari Therapeutics PlcWarrants to purchase American Depositary Shares ("ADRs") | Farag Kameel D. | Purchase |
| Nov 1, 2025 | Akari Therapeutics PlcAmerican Depositary Shares representing Ordinary Shares | Farag Kameel D. | Stock award |
| Nov 1, 2025 | Akari Therapeutics PlcAmerican Depositary Shares representing Ordinary Shares | Farag Kameel D. | Stock award |
| Oct 22, 2025 | Akari Therapeutics PlcAmerican Depositary Shares representing Ordinary Shares | Farag Kameel D. | Stock award |
Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.
Transactions in associated filings
| Filed / transacted | Company | Reporting owners | Type / security | Quantity | Price / reference value | Details |
|---|---|---|---|---|---|---|
| Trade: | Akari Therapeutics PlcAKTX · company listings | Farag Kameel D.Interim CFO | PurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P | 24,745 | 0.4041 *Value: 9,999.4545Currency not specified | View ↗ |
| Trade: | Akari Therapeutics PlcAKTX · company listings | Farag Kameel D.Interim CFO | PurchaseWarrants to purchase American Depositary Shares ("ADRs")Derivative security · Code P | 24,745 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Akari Therapeutics PlcAKTX · company listings | Farag Kameel D.Interim CFO | Stock awardAmerican Depositary Shares representing Ordinary SharesNon-derivative security · Code A | 26,619 | 0.75Value: 19,964.25Currency not specified | View ↗ |
| Trade: | Akari Therapeutics PlcAKTX · company listings | Farag Kameel D.Interim CFO | Stock awardAmerican Depositary Shares representing Ordinary SharesNon-derivative security · Code A | 32,000 | 0.75Value: 24,000Currency not specified | View ↗ |
| Trade: | Akari Therapeutics PlcAKTX · company listings | Farag Kameel D.Interim CFO | Stock awardAmerican Depositary Shares representing Ordinary SharesNon-derivative security · Code A | 6,277 | 0.74Value: 4,644.98Currency not specified | View ↗ |
5 transactions on this page. Filing date, newest first.